Lack of association between plasma Dehydroepiandrosterone Sulfate (DHEA-S) levels and depression in hemodialysis patients: A cross-sectional study

Experimental Gerontology

Volumn 44, Issue 11, 2009, Pages 733-739

  Hsu, Heng Jung ^a,b   Chen, Chih Ken ^a,b   Hsiao, Cheng Cheng ^a,b   Wu, I Wen ^a,b   Sun, Chiao Yin ^a,b   Chou, Chia Chi ^a,b   Lee, Chin Chan ^a,b   Tsai, Chi Jen ^a,b   Wu, Mai Szu ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Depression; DHEA S; End stage renal disease; Hemodialysis; Steroid hormone

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; PRASTERONE SULFATE; UREA;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT DURATION;

CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSIVE DISORDER; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; TAIWAN;

EID: 70350375283     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.08.009     Document Type: Article

References (57)

1. Barrett-Connor E., and Edelstein S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 42 (1994) 420-423
2. Barrett-Connor E., Khaw K.T., and Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med. 315 (1986) 1519-1524
3. Barrett-Connor E., von Muhlen D., Laughlin G.A., and Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 47 (1999) 685-691
4. Baulieu E.E. Dehydroepiandrosterone (DHEA): a fountain of youth?. J. Clin. Endocrinol. Metab. 81 (1996) 3147-3151
5. Baulieu E.E., and Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150 Suppl. (1996) S221-S239
6. Berr C., Lafont S., Debuire B., Dartigues J.F., and Baulieu E.E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. USA 93 (1996) 13410-13415
7. Byrne J.J., and Bradlow H.L. DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat. Diabetes Technol. Ther. 3 (2001) 211-219
8. Corpechot C., Robel P., Axelson M., Sjovall J., and Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. USA 78 (1981) 4704-4707
9. Danielski M., Ikizler T.A., McMonagle E., Kane J.C., Pupim L., Morrow J., and Himmelfarb J. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am. J. Kidney Dis. 42 (2003) 286-294
10. De Pergola G., Cospite M.R., Giagulli V.A., Giorgino F., Garruti G., Cignarelli M., and Giorgino R. Insulin-like growth factor-1 (IGF-1) and dehydroepiandrosterone sulphate in obese women. Int. J. Obes. Relat. Metab. Disord. 17 (1993) 481-483
11. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 169-192
12. Ebeling P., and Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet 343 (1994) 1479-1481
13. Glei D.A., Goldman N., Weinstein M., and Liu I.W. Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex?. Exp. Gerontol. 39 (2004) 321-331
14. Goldman N., and Glei D.A. Sex differences in the relationship between DHEAS and health. Exp. Gerontol. 42 (2007) 979-987
15. Goodyer I.M., Herbert J., and Altham P.M. Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol. Med. 28 (1998) 265-273
16. Guevara A., Vidt D., Hallberg M.C., Zorn E.M., Pohlman C., and Wieland R.G. Serum gonadotropin and testosterone levels in uremic males undergoing intermittent dialysis. Metabolism 18 (1969) 1062-1066
17. Herbert J. Neurosteroids, brain damage, and mental illness. Exp. Gerontol. 33 (1998) 713-727
18. Herrmann C. International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J. Psychosom. Res. 42 (1997) 17-41
19. Holdsworth S., Atkins R.C., and de Kretser D.M. The pituitary-testicular axis in men with chronic renal failure. N. Engl. J. Med. 296 (1977) 1245-1249
20. Hsiao C.C. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression. Psychoneuroendocrinology 31 (2006) 839-846
21. Hsu H.J., Chen C.K., and Wu M.S. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers. Am. J. Nephrol. 29 (2009) 592-597
22. Inaudi P., De Leo V., De Leo M., Verzetti G., D'Antona N., and Genazzani A.R. Changes in plasma concentrations of adrenal androgens in patients with chronic renal insufficiency. Boll. Soc. Ital. Biol. Sper. 59 (1983) 1861-1867
23. Kalender B., Mutlu B., Ersoz M., Kalkan A., and Yilmaz A. The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. Int. J. Clin. Pract. 56 (2002) 505-508
24. Kalender B., Ozdemir A.C., and Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin. Pract. 102 (2006) c115-121
25. Kawano H., Yasue H., Kitagawa A., Hirai N., Yoshida T., Soejima H., Miyamoto S., Nakano M., and Ogawa H. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J. Clin. Endocrinol. Metab. 88 (2003) 3190-3195
26. Kiechl S., Willeit J., Bonora E., Schwarz S., and Xu Q. No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study). Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1094-1100
27. Kimmel P.L. Psychosocial factors in dialysis patients. Kidney Int. 59 (2001) 1599-1613
28. Kimmel P.L., Weihs K., and Peterson R.A. Survival in hemodialysis patients: the role of depression. J. Am. Soc. Nephrol. 4 (1993) 12-27
29. Kimmel P.L., Peterson R.A., Weihs K.L., Simmens S.J., Alleyne S., Cruz I., and Veis J.H. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 57 (2000) 2093-2098
30. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., and Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 95 (1998) 1852-1857
31. Lopes A.A., Bragg J., Young E., Goodkin D., Mapes D., Combe C., Piera L., Held P., Gillespie B., and Port F.K. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 62 (2002) 199-207
32. Lowrie E.G. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am. J. Kidney Dis. 32 (1998) S105-112
33. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
34. Majewska M.D., Demirgoren S., Spivak C.E., and London E.D. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 526 (1990) 143-146
35. Martin C.R., and Thompson D.R. The hospital anxiety and depression scale in patients undergoing peritoneal dialysis: Internal and test re-test reliability. Clin. Eff. Nurs. 6 (2002) 77-79
36. Mastrogiacomo I., De Besi L., Zucchetta P., Serafini E., La Greca G., Gasparotto M.L., Lorenzi S., and Dean P. Male hypogonadism of uremic patients on hemodialysis. Arch. Androl. 20 (1988) 171-175
37. May M., Holmes E., Rogers W., and Poth M. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sci. 46 (1990) 1627-1631
38. Mazat L., Lafont S., Berr C., Debuire B., Tessier J.F., Dartigues J.F., and Baulieu E.E. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci. USA 98 (2001) 8145-8150
39. Michael A., Jenaway A., Paykel E.S., and Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol. Psychiatry 48 (2000) 989-995
40. Morales A.J., Nolan J.J., Nelson J.C., and Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78 (1994) 1360-1367
41. Morsink L.F., Vogelzangs N., Nicklas B.J., Beekman A.T., Satterfield S., Rubin S.M., Yaffe K., Simonsick E., Newman A.B., Kritchevsky S.B., and Penninx B.W. Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology 32 (2007) 874-883
42. Nieszporek T., Witkowicz J., Nowak L., Chudek J., and Wiecek A. Low plasma dehydroepiandrosterone sulfate level and its relationship to adiponectin in hemodialysis patients. Ren. Fail. 29 (2007) 417-421
43. I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000, 2001. Am. J. Kidney Dis. 37 (1, Suppl. 1), S7-S64.
44. Olsson I., Mykletun A., and Dahl A.A. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5 (2005) 46
45. Plager J.E. The binding of androsterone sulfate, ethiocholanolone sulfate, and dehydroisoandrosterone sulfate by human plasma protein. J. Clin. Invest. 44 (1965) 1234-1239
46. Roth G.S., Lane M.A., Ingram D.K., Mattison J.A., Elahi D., Tobin J.D., Muller D., and Metter E.J. Biomarkers of caloric restriction may predict longevity in humans. Science 297 (2002) 811
47. Starkman M.N., Schteingart D.E., and Schork M.A. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom. Med. 43 (1981) 3-18
48. Stewart-Bentley M., Gans D., and Horton R. Regulation of gonadal function in uremia. Metabolism 23 (1974) 1065-1072
49. Takebayashi M., Kagaya A., Uchitomi Y., Kugaya A., Muraoka M., Yokota N., Horiguchi J., and Yamawaki S. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication. J. Neural. Transm. 105 (1998) 537-542
50. Taskapan H., Ates F., Kaya B., Emul M., Kaya M., Taskapan C., and Sahin I. Psychiatric disorders and large interdialytic weight gain in patients on chronic haemodialysis. Nephrology (Carlton) 10 (2005) 15-20
51. Tweed A.E., Metcalfe M., and Taylor R. Mood and quality of life in kidney transplant patients: is there an influence of organ source?. Proc. Br. Psychol. Soc. Annu. Conf. 10 (2002) 104
52. Vasdev S., Johnson E., Longerich L., Prabhakaran V.M., and Gault M.H. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. Clin. Nephrol. 27 (1987) 169-174
53. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., Joyce P.R., Karam E.G., Lee C.K., Lellouch J., Lepine J.P., Newman S.C., Rubio-Stipec M., Wells J.E., Wickramaratne P.J., Wittchen H., and Yeh E.K. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276 (1996) 293-299
54. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., and Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol. Psychiatry 41 (1997) 311-318
55. Wright B.E., Porter J.R., Browne E.S., and Svec F. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 16 (1992) 579-583
56. Yaffe K., Ettinger B., Pressman A., Seeley D., Whooley M., Schaefer C., and Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry 43 (1998) 694-700
57. Zumoff B., Walter L., Rosenfeld R.S., Strain J.J., Degen K., Strain G.W., Levin J., and Fukushima D. Subnormal plasma adrenal androgen levels in men with uremia. J. Clin. Endocrinol. Metab. 51 (1980) 801-805